Bile acids‐mediated overexpression of MUC4 via FAK‐dependent c‐Jun activation in pancreatic cancer
暂无分享,去创建一个
S. Batra | R. Brand | M. P. Ponnusamy | S. Guha | Sushil Kumar | S. Rachagani | S. Joshi | Eric Cruz | Suhasini Joshi | M. Ponnusamy
[1] Lynette M. Smith,et al. The canonical Wnt pathway regulates the metastasis‐promoting mucin MUC4 in pancreatic ductal adenocarcinoma , 2016, Molecular oncology.
[2] Jia-Hong Chen,et al. Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive Jaundices , 2015, Medicine.
[3] S. Batra,et al. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells , 2015, Oncotarget.
[4] S. Batra,et al. Genetically engineered mucin mouse models for inflammation and cancer , 2015, Cancer and Metastasis Reviews.
[5] S. Batra,et al. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer , 2014, Oncogene.
[6] S. Batra,et al. Altered Mucins (MUC) Trafficking in Benign and Malignant Conditions , 2014, Oncotarget.
[7] Lynette M. Smith,et al. Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages , 2014, Oncogene.
[8] Xi Chen,et al. Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. , 2014, Cancer research.
[9] S. Batra,et al. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. , 2013, Cancer letters.
[10] S. Batra,et al. Mucins in pancreatic cancer and its microenvironment , 2013, Nature Reviews Gastroenterology &Hepatology.
[11] D. Sifrim,et al. Investigation of extraesophageal gastroesophageal reflux disease , 2013, Annals of gastroenterology.
[12] M. Wallace,et al. Neutrophil Gelatinase-Associated Lipocalin, Macrophage Inhibitory Cytokine 1, and Carbohydrate Antigen 19-9 in Pancreatic Juice: Pathobiologic Implications in Diagnosing Benign and Malignant Disease of the Pancreas , 2013, Pancreas.
[13] D. Sifrim. Management of bile reflux. , 2013, Gastroenterology & hepatology.
[14] J. Lobaccaro,et al. Bile acids: from digestion to cancers. , 2013, Biochimie.
[15] Lynette M. Smith,et al. Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer , 2013, PloS one.
[16] S. Batra,et al. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy , 2012, Journal of Hematology & Oncology.
[17] Weiling Zhao,et al. Radiation-Induced c-Jun Activation Depends on MEK1-ERK1/2 Signaling Pathway in Microglial Cells , 2012, PloS one.
[18] M. Halpern,et al. Active Transport of Bile Acids Decreases Mucin 2 in Neonatal Ileum: Implications for Development of Necrotizing Enterocolitis , 2011, PloS one.
[19] Yixing Chen,et al. Cholecystectomy and risk of pancreatic cancer: a meta-analysis of observational studies , 2011, Cancer Causes & Control.
[20] A. Moschetta,et al. Bile acids and colon cancer: Solving the puzzle with nuclear receptors. , 2011, Trends in molecular medicine.
[21] H. Barr,et al. Barrett's esophagus: genetic and cell changes , 2011, Annals of the New York Academy of Sciences.
[22] R. Bresalier,et al. Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3‐kinase/protein kinase C/activator protein‐1 pathway , 2011, Cancer.
[23] J. Y. Lee,et al. Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion , 2011, British Journal of Cancer.
[24] S. Kwon,et al. Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway. , 2010, International journal of oncology.
[25] Amitava Das,et al. FXR Promotes Endothelial Cell Motility Through Coordinated Regulation of FAK and MMP-9 , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[26] Min Jung Park,et al. Bile acid regulates c-Jun expression through the orphan nuclear receptor SHP induction in gastric cells. , 2008, Biochemical and biophysical research communications.
[27] A. Benson,et al. Inoperable pancreatic cancer: standard of care. , 2007, Oncology.
[28] P. Chaturvedi,et al. Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells , 2007, British Journal of Cancer.
[29] Jane L Meza,et al. MUC4 Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins , 2007, Molecular Cancer Research.
[30] M. Copin,et al. Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha. , 2007, The Biochemical journal.
[31] M. Copin,et al. MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms , 2007, Oncogene.
[32] K. Franchini,et al. Focal adhesion kinase mediates MEF2 and c-Jun activation by stretch: role in the activation of the cardiac hypertrophic genetic program. , 2005, Cardiovascular research.
[33] J. Meza,et al. Synergistic induction of the MUC4 mucin gene by interferon-γ and retinoic acid in human pancreatic tumour cells involves a reprogramming of signalling pathways , 2005, Oncogene.
[34] R. Hruban,et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.
[35] N. Carragher,et al. Src-Mediated Phosphorylation of Focal Adhesion Kinase Couples Actin and Adhesion Dynamics to Survival Signaling , 2004, Molecular and Cellular Biology.
[36] S. Batra,et al. Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway. , 2004, The Biochemical journal.
[37] Christine A Iacobuzio-Donahue,et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. , 2003, Cancer research.
[38] H. Shirasawa,et al. Survival regulation in pancreatic cancer cells by c-Jun. , 2003, International journal of oncology.
[39] Eugene M. Johnson,et al. JNK-independent Activation of c-Jun during Neuronal Apoptosis Induced by Multiple DNA-damaging Agents* , 2003, Journal of Biological Chemistry.
[40] R. DePinho,et al. Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.
[41] Hirotoshi Nakamura,et al. Treatment of Common Bile Duct Obstruction by Pancreatic Cancer Using Various Stents: Single-Center Experience , 2002, CardioVascular and Interventional Radiology.
[42] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[43] H. Friess,et al. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[44] P. Fisher,et al. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. , 2001, Molecular biology of the cell.
[45] P. Dent,et al. Down-regulation of Cholesterol 7α-Hydroxylase (CYP7A1) Gene Expression by Bile Acids in Primary Rat Hepatocytes Is Mediated by the c-Jun N-terminal Kinase Pathway* , 2001, The Journal of Biological Chemistry.
[46] Fan Zhang,et al. Dihydroxy Bile Acids Activate the Transcription of Cyclooxygenase-2* , 1998, The Journal of Biological Chemistry.
[47] R. Metzgar,et al. Ultrastructural Differentiation of Sodium Butyrate‐Treated Human Pancreatic Adenocarcinoma Cell Lines , 1991, Pancreas.
[48] T. Chalmers,et al. A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer , 1990, Cancer Causes & Control.
[49] D. Carter,et al. Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model. , 1985, British Journal of Cancer.
[50] N. Yamaguchi,et al. Establishment and characterization of a carcinoembryonic antigen (CEA)‐producing cell line from a human carcinoma of the exocrine pancreas , 1983, Cancer.
[51] K. Takano,et al. Age-related changes in cholesterol and bile acid metabolism in rats. , 1978, Journal of lipid research.
[52] L. Foulds. Mammary Tumours in Hybrid Mice: Growth and Progression of Spontaneous Tumours , 1949, British Journal of Cancer.
[53] P. Chaturvedi,et al. Human MUC 4 mucin induces ultrastructural changes and tumorigenicity in pancreatic cancer cells , 2015 .
[54] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[55] C. Mariette,et al. Activation of MUC1 mucin expression by bile acids in human esophageal adenocarcinomatous cells and tissues is mediated by the phosphatidylinositol 3-kinase. , 2008, Surgery.
[56] J. Meza,et al. MUC 4 Mucin Potentiates Pancreatic Tumor Cell Proliferation , Survival , and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins , 2007 .
[57] G. Tessari,et al. The expression of proto-oncogene c-jun in human pancreatic cancer. , 1999, Anticancer research.
[58] R. Tungtrongchitr,et al. Serum unconjugated primary and secondary bile acids in patients with cholangiocarcinoma and hepatocellular carcinoma. , 1990, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[59] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[60] J. Scholefield,et al. Abdominal wall and gastric infarction in acute pancreatitis. , 1988, Pancreas.